Inorevia Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 16

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $1.59M

  • Investors
  • 8

Inorevia General Information

Description

Developer of sample preparation instruments designed for next-generation bioassay and precision medicine. The company utilizes a combination of microfluidics, computer-assisted flow control, and magnetic particles to develop a technology for automating biological analysis processes to drastically reduce reagents and sample consumption, enabling clients to accelerate complex biology protocols and reduce downtimes.

Contact Information

Website
www.inorevia.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 8 Avenue Louis Pasteur
  • Batiment D
  • 92220 Bagneux
  • France
Primary Industry
Biotechnology
Other Industries
Other Devices and Supplies
Vertical(s)
Life Sciences
Corporate Office
  • 8 Avenue Louis Pasteur
  • Batiment D
  • 92220 Bagneux
  • France

Inorevia Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Inorevia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 04-Jan-2023 $1.59M Completed Generating Revenue
7. Accelerator/Incubator 01-Jan-2022 Completed Generating Revenue
6. Accelerator/Incubator Completed Generating Revenue
5. Accelerator/Incubator Completed Generating Revenue
4. Grant 30-Sep-2021 Completed Generating Revenue
3. Angel (individual) 07-Jul-2020 Completed Generating Revenue
2. Grant 17-Jul-2018 $468K $514K Completed Generating Revenue
1. Angel (individual) 05-Feb-2018 $514K $514K Completed Startup
To view Inorevia’s complete valuation and funding history, request access »

Inorevia Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary Shares
Ordinary Shares
Ordinary Shares 17,458 $0.106071 $25.46 $25.46 1x $25.46 8.56%
To view Inorevia’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Inorevia Patents

  • 3

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

Inorevia Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210229100-A1 Method of manipulating droplets in a channel Active 27-Jun-2018
EP-3586964-A1 Method of manipulating droplets in a channel Pending 27-Jun-2018
US-12239984-B2 Method of manipulating droplets in a channel Active 27-Jun-2018 B01L3/502784

Inorevia Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Inorevia Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
iXCore Venture Capital Minority
One Green (Paris) Venture Capital Minority
WeLikeStartup Accelerator/Incubator Minority
Paris Biotech Sante Accelerator/Incubator
European Union Government
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

Inorevia FAQs

  • When was Inorevia founded?

    Inorevia was founded in 2016.

  • Where is Inorevia headquartered?

    Inorevia is headquartered in Bagneux, France.

  • What is the size of Inorevia?

    Inorevia has 16 total employees.

  • What industry is Inorevia in?

    Inorevia’s primary industry is Biotechnology.

  • Is Inorevia a private or public company?

    Inorevia is a Private company.

  • What is the current valuation of Inorevia?

    The current valuation of Inorevia is .

  • What is Inorevia’s current revenue?

    The current revenue for Inorevia is .

  • How much funding has Inorevia raised over time?

    Inorevia has raised $2.92M.

  • Who are Inorevia’s investors?

    iXCore, One Green (Paris), WeLikeStartup, Paris Biotech Sante, and European Union are 5 of 8 investors who have invested in Inorevia.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »